4Filed Aug 5, 8:00 PM ET

Attovia (ATTO) CFO Receives Award of 538,300 Derivative Shares

$ATTO · Attovia Therapeutics, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Attovia (ATTO) CFO Receives Award of 538,300 Derivative Shares

What Happened
The company’s Chief Financial Officer (CFO) received a grant/award of 538,300 derivative shares (reported as a $0.00 acquisition) on August 4, 2026. The filing shows an acquisition code "A" (award/grant) and a reported aggregate value of $0.00 for the transaction. This is a compensation award rather than an open-market purchase or sale.

Key Details

  • Transaction date: August 4, 2026; Form 4 filed August 6, 2026 (appears timely under the two-business-day rule).
  • Security and amount: 538,300 derivative shares/options reported at $0.00 per share. Transaction code: A (award/grant).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Vesting footnote: 25% of the options vest on August 4, 2027; the remaining options vest in equal monthly installments over the following 36 months, subject to continued service to the issuer.
  • No indication these shares were sold or exercised immediately; this is an equity compensation award, not a market trade.

Context
This is a standard equity-based compensation award to an executive—useful to note for potential future dilution as the awards vest. Awards do not by themselves signal buying or selling intent in the market; they reflect compensation arrangements and service-based vesting.